The U.S. Federal Trade Commission was considering a lawsuit to block the company’s about $7 billion takeover by Walgreens Boots Alliance Inc.
The timeline to complete the deal has been extended until July 31 as antitrust regulators review it. Rite Aid is trading far below the deal price, which Walgreens and Rite
Aid reduced to a range of $6.50 to $7 a share in January. In March,
Walgreens was said to be poised to sell more assets to help the deal go forward.. . . more